 HYDERABAD, India PRINCETON, N.J.--BUSINESS WIRE--Dr. Reddys Laboratories Ltd. BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as Dr. Reddys today announced the launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, 5 mg2.5 mg, a therapeutic equivalent generic version of Librax chlordiazepoxide hydrochloride and clidinium bromide approved by the U.S. Food and Drug Administration USFDA. The Librax bran 